Transgene SA (TNG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Transgene SA (TNG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Transgene SA (TNG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Transgene SA (TNG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
44 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Transgene SA (Transgene) is a biopharmaceutical company that discovers and develops pipeline of immunotherapies in the areas of cancer and infectious diseases. The company offers pipeline products such as TG4010, Pexa-Vec, TG6002, TG1050, and TG4001. It offers TG1050 and various candidates for chronic hepatitus B and tuberculosis. Transgenes clinical trials are used in the treatment of metastatic non-small cell lung cancer, hepatocellular carcinoma, HPV-induced cancer, cervical intraepithelial neoplasia and solid tumors. It provides clinical-stage programs for non-small cell lung cancer and Pexa-Vec for liver cancer. The company operates through its subsidiaries in the US and China.

Transgene SA (TNG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped th

  
Source:
Document ID
GDPH81795D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
Transgene SA, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201652
Transgene SA, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201671
Transgene SA, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201681
Transgene SA, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201691
Transgene SA, Medical Devices Deals, 2010 to YTD 2016101
Transgene SA, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016112
Transgene SA, Pharmaceuticals &Healthcare, Deal Details1328
  Venture Financing131
    Jennerex Biotherapeutics Raises US$21.6 Million In Venture Financing131
    ElsaLys Biotech Raises US$2.7 Million In First Round Of Financing142
  Partnerships161
    Transgene and SillaJen Amends Agreement161
    Transgene Enters Into Co-Development Agreement With Ligue nationale contre le cancer For Anticancer Biotherapies171
    Tianjin Tasly Forms Joint Venture With Transgene181
  Licensing Agreements191
    Novartis Terminates Option For Licensing Agreement With Transgene For TG4010191
    Transgene Enters Into Licensing Agreement With Ascend Biopharma For TG1042201
    Vivalis Enters Into Licensing Agreement With Transgene For Vaccines211
    ISA Pharma Enters Into Licensing Agreement With Transgene221
    Roche Terminates Licensing Agreement With Transgene231
    Virax Holdings Enters Into Licensing Agreement With Transgene For Skin Cancer Drug242
    Jennerex Enters Into Licensing Agreement With Transgene For JX-594262
    Transgene To Enter Into License Agreement For An Experimental Cancer Antibody281
    Transgene Enters Into Option Licensing Agreement With Novartis292
    Crucell Enters Into Licensing Agreement With Transgene311
  Equity Offering321
    Transgene Completes Rights Offering Of Shares For US$62.4 Million322
    Transgene Completes Private Placement of Shares for up to USD27.44 Million342
    Transgene Completes Rights Offering For US$228 Million362
  Asset Transactions381
    Advanced BioScience Labs Acquires Production Asset of Transgene381
  Acquisition391
    SillaJen Completes Acquisition Of Jennerex For US$150 Million392
Transgene SA - Key Competitors411
Key Employees421
Locations And Subsidiaries431
  Head Office431
  Other Locations &Subsidiaries431
Appendix441
  Methodology441
  About GlobalData441
  Contact Us441
  Disclaimer441

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Transgene SA (TNG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Transgene-SA-TNG-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13964>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Transgene SA (TNG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Transgene-SA-TNG-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13964>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research